Literature DB >> 20883069

Gastrointestinal carcinoid tumors.

M J Varas-Lorenzo1, F Muñoz-Agel, J C Espinós-Pérez, M Bardají-Bofill.   

Abstract

OBJECTIVE: carcinoid tumors (CTs) represent the commonest neuroendocrine tumors. Those in the gastrointestinal tract are diagnosed in surgical specimens, clinically, and using imaging techniques (endoscopy, echoendoscopy, CT, Octreoscan, etc.). The goal of this retrospective study was to review a personal series of gastrointestinal carcinoid tumors, and to compare it to those in the literature. PATIENTS AND METHODS: the medical records of 40 Caucasian patients with over 50 gastrointestinal carcinoid tumors (including multiple cases) who were seen for a period of 16 years (1994-2009) were reviewed.
RESULTS: mean age at presentation was 52 years, 50% were females, and mean tumor size was 9.9 mm. Most were gastroduodenal (42.5%) or rectal (30%), and were treated endoscopically. Metastases and carcinoid syndrome (CS) were seen in 5% of patients. Survival at study endpoint was 85%.
CONCLUSIONS: age and gender were consistent with the literature. There was an increase in gastroduodenal (multifocal) and rectal carcinoids, likely because the series was essentially endoscopical in nature (bias). There was a lower rate of CS and higher survival, likely due to earlier diagnosis and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20883069     DOI: 10.4321/s1130-01082010000900004

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  2 in total

1.  Usefulness of endoscopic resection using the band ligation method for rectal neuroendocrine tumors.

Authors:  Ju Seung Kim; Yoon Jae Kim; Jun-Won Chung; Jung Ho Kim; Kyoung Oh Kim; Kwang An Kwon; Dong Kyun Park; Jung Suk An
Journal:  Intest Res       Date:  2016-04-27

2.  Evaluation of colonoscopy in the diagnosis and treatment of rectal carcinoid tumors with diameter less than 1 cm in 21 patients.

Authors:  Jing Liu; Zh-Qiang Wang; Zi-Qi Zhang; Xiao Chen; Yu Zhang
Journal:  Oncol Lett       Date:  2013-02-27       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.